2404-2405 / 2953
CHHiP study comparing standard
and hypofractionated RT+ADT
•
No increased toxicity for hypofractionated regimes at
2 years – efficacy results awaited
Patients (%)
Patients (%)
Bladder toxicity*
Bowel toxicity*
Dearnaley D, et al. Lancet Oncol 2012;13(1):43-54
* Radiation Therapy Oncology Group Grade scores
42